By using genetically tractable mouse models of iCCA to understand the effect of DKK1 overexpression on the tumour immune microenvironment, we have shown that DKK1 is sufficient to drive profound immune changes within tumours. The gene discussed is DKK1; the disease is infantile convulsions and choreoathetosis.